SCI Pharmtech Inc is a Taiwan-based company mainly engaged in the research, development, manufacturing, and sales of active pharmaceutical ingredients (APIs), API intermediates, and specialty and precision chemicals. The Company's main product categories are APIs, API intermediates, and specialty chemicals. The Company primarily sells its products in Europe, Asia, the Americas, and other domestic and international markets.

Employees

239

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
17/09/26	NT$58.20	-1.69%	183,175
17/09/26	NT$59.20	-0.84%	156,628
16/09/26	NT$59.70	+0.17%	188,754
15/09/26	NT$59.60	+2.76%	318,971
14/09/26	NT$58.00	-0.51%	163,842

End-of-day quote Taiwan S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

End-of-day quote Taiwan S.E. 18/09/2026			5-day change	1st Jan Change
58.20 ^TWD	-1.69%		+0.52%	+19.51%

08-06	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-07	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	6.96B 219M 191M 180M 163M 306M 20.97B 307M 2.16B 832M 10.66B 821M 803M 34.3B	P/E 2024	20.3x	P/E 2025	54.2x
Enterprise Value	7.87B 247M 216M 204M 185M 346M 23.72B 348M 2.44B 941M 12.06B 929M 908M 38.8B	EV / Sales 2024	7.3x	EV / Sales 2025	5.01x
Free-Float	54.76%	Yield 2024	1.66%	Yield 2025	1.54%

08-06	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-07	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-05	SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-05	SCI Pharmtech, Inc. Proposes Dividend Distribution for the Period from January 1, 2025 to December 31, 2025	CI
11-07	SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
06/08/25	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
05/06/25	SCI Pharmtech, Inc. Announces Cash Dividend, Payable on August 5, 2025	CI
26/05/25	SCI Pharmtech, Inc. Announces Changes to its Board, Effective May 26, 2025	CI
08/05/25	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
10/03/25	Sci Pharmtech, Inc. Declares Dividend for Period from January 01, 2024 to December 31, 2024	CI
09/03/25	SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
09/01/25	Sci Pharmtech, Inc. Announces Cash Dividend Payment	CI
20/12/24	Sci Pharmtech, Inc. Announces Appointment of Members of the Sustainable Development Committee	CI

29/06/22	SCI Pharmtech : Notice of appointment of general manager of the Board of Directors.	PU
29/06/22	SCI Pharmtech : Notice of the re-election of chairman of the Board of Directors.	PU
21/06/22	SCI Pharmtech : List of the Company's elected directors.	PU
21/06/22	SCI Pharmtech : Notice of the resolutions of 2022 general shareholders' meeting.	PU
21/06/22	SCI Pharmtech : Notice of re-election of functional committees' members	PU

SCI Pharmtech, Inc. Share Price

Stocks

4119

TW0004119003

Pharmaceuticals

Valuation: SCI Pharmtech, Inc.

Chart: SCI Pharmtech, Inc.

Latest news: SCI Pharmtech, Inc.

Press Releases: SCI Pharmtech, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: SCI Pharmtech, Inc.

Specialty & Advanced Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

1 day	-1.69%
1 week	+0.52%
Current month	+5.05%
1 month	+8.99%
3 months	+34.26%
6 months	+6.20%
Current year	+19.51%

1 week	57.3	60.7
1 month	51.6	60.7
Current year	39.6	60.7
1 year	39.6	61
3 years	39.6	101.5
5 years	39.6	119.56
10 years	39.6	119.56

Manager	Title	Age	Since
Wei Chun Weng CEO	Chief Executive Officer	-	-
Wen Chen Yang DFI	Director of Finance/CFO	-	31/12/2002
Wen Chih Chou PRN	Corporate Officer/Principal	-	31/08/2010

Director	Title	Age	Since
Wei Chun Weng CHM	Chairman	-	16/12/2001
Hsiang Li Chen BRD	Director/Board Member	-	16/12/2001
Wen Chih Chou BRD	Director/Board Member	-	31/08/2010

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCI PHARMTECH, INC.	-1.69%	+0.52%	+1.22%	-39.88%	222M
MERCK & CO., INC.	-0.67%	+1.37%	+78.96%	+35.32%	363B
MERCK KGAA	-1.22%	-1.22%	+20.85%	-19.25%	65.62B
HALOZYME THERAPEUTICS, INC.	+1.86%	+3.73%	+45.02%	+184.33%	12.45B
KYOWA KIRIN CO., LTD.	-0.29%	+2.27%	-5.37%	-16.54%	7.6B
SK BIOPHARMACEUTICALS CO., LTD.	-1.89%	-6.83%	-27.65%	-14.90%	4.49B
YUHAN CORPORATION	-2.06%	-3.80%	-34.68%	+5.56%	4.19B
BETTA PHARMACEUTICALS CO., LTD.	+1.48%	+2.36%	-31.20%	-13.91%	2.92B
SUPERNUS PHARMACEUTICALS, INC.	-2.38%	+0.74%	-9.06%	+48.18%	2.49B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-0.41%	-0.71%	-28.25%	-33.78%	1.93B
Average	-0.76%	+0.49%	+0.98%	+13.51%	46.5B
Weighted average by Cap.	-0.75%	+1.38%	+64.77%	+29.45%

	2024	2025
Net sales	1.52B 47.87M 41.75M 39.42M 35.79M 67.06M 4.59B 67.34M 472M 182M 2.34B 180M 176M 7.51B	1.34B 42.22M 36.81M 34.76M 31.57M 59.14M 4.05B 59.39M 416M 161M 2.06B 159M 155M 6.63B
Net income	535M 16.8M 14.65M 13.83M 12.56M 23.53M 1.61B 23.63M 166M 63.94M 820M 63.11M 61.7M 2.64B	107M 3.37M 2.94M 2.78M 2.52M 4.73M 324M 4.75M 33.27M 12.84M 165M 12.67M 12.39M 530M
Net Debt	298M 9.35M 8.15M 7.7M 6.99M 13.1M 897M 13.15M 92.23M 35.59M 456M 35.13M 34.35M 1.47B	912M 28.67M 25M 23.6M 21.43M 40.16M 2.75B 40.32M 283M 109M 1.4B 108M 105M 4.5B